Brexpiprazole for Treating Mood and Psychotic Disorders, and Dementia in Alzheimer's Disease
Tracking # 20-1112894
Course overview
Brexpiprazole is an atypical, second-generation antipsychotic primarily used to treat adults with schizophrenia, a mental disorder characterized by hallucinations, delusions, and disorganized thinking. It is also approved for the adjunctive treatment of major depressive disorder (MDD) in adults, which means it can be used alongside an antidepressant to enhance its effects. Certain medical conditions, such as liver impairment or a history of seizures, may require dosage adjustments or monitoring. Brexpiprazole may also increase the risk of suicidal thoughts or behavior, particularly in younger individuals with major depressive disorder.
Subject areas
This course counts toward the state boards and subject areas below.